InvestSMART

Revolution Medicines (NASDAQ: RVMD) - Share Price

Current share price for RVMD : $207.880 13.27 (6%)+

Currency: USD ($)

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

RVMD General Information +

NASDAQ Code RVMD
Industry/Sector Biotechnology
Market Cap ($M) 44,556
RVMD Share Price $207.880
Day High $220.810
Day Low $205.820
Last Close $221.150
RVMD Share Price Movement $13.27 ( 6% )
Prices as at 4:04, 29 Aug 2026
+Security prices are at best end-of-day and are indicative only.

RVMD Financial Summary

Operating Revenue Per Share Price to Operating revenue Price to free cash flow Earnings Yield PE Ratio Dividend Yield Forward Dividend Yield Forward Earnings Yield
$0.12 $1,702.70 ($25.95) n/a n/a n/a -3.97

RVMD Calendar of Events

Created Date Changed Date Event
28 April 2026 28 April 2026 Company Meeting

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.